A detailed history of Rothschild Investment LLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Rothschild Investment LLC holds 80 shares of URGN stock, worth $849. This represents 0.0% of its overall portfolio holdings.

Number of Shares
80
Previous 30 166.67%
Holding current value
$849
Previous $381,000 123.62%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 04, 2025

BUY
$10.52 - $13.11 $526 - $655
50 Added 166.67%
80 $852,000
Q3 2024

Oct 18, 2024

BUY
$12.7 - $17.92 $381 - $537
30 New
30 $381,000

Others Institutions Holding URGN

About UroGen Pharma Ltd.


  • Ticker URGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,740,500
  • Market Cap $242M
  • Description
  • UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...
More about URGN
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.